Beneficial cardiovascular pleiotropic effects of statins
- PMID: 15198965
- DOI: 10.1161/01.CIR.0000131517.20177.5a
Beneficial cardiovascular pleiotropic effects of statins
Abstract
Pleiotropic effects of a drug are actions other than those for which the agent was specifically developed. These effects may be related or unrelated to the primary mechanism of action of the drug, and they are usually unanticipated. Pleiotropic effects may be undesirable (such as side effects or toxicity), neutral, or, as is especially the case with HMG-CoA reductase inhibitors (statins), beneficial. Pleiotropic effects of statins include improvement of endothelial dysfunction, increased nitric oxide bioavailability, antioxidant properties, inhibition of inflammatory responses, and stabilization of atherosclerotic plaques. These and several other emergent properties could act in concert with the potent low-density lipoprotein cholesterol-lowering effects of statins to exert early as well as lasting cardiovascular protective effects. Understanding the pleiotropic effects of statins is important to optimize their use in treatment and prevention of cardiovascular disease.
Similar articles
-
Pleiotropic effects of statins: evidence for benefits beyond LDL-cholesterol lowering.Am J Cardiovasc Drugs. 2010;10 Suppl 1:3-9. doi: 10.2165/1153644-S0-000000000-00000. Am J Cardiovasc Drugs. 2010. PMID: 21391728 Review.
-
[Do the pleiotropic effects of statins have a clinical significance?].Arch Mal Coeur Vaiss. 2004 Dec;97(12):1231-5. Arch Mal Coeur Vaiss. 2004. PMID: 15669365 Review. French.
-
Endothelium-dependent effects of statins.Arterioscler Thromb Vasc Biol. 2003 May 1;23(5):729-36. doi: 10.1161/01.ATV.0000063385.12476.A7. Epub 2003 Feb 27. Arterioscler Thromb Vasc Biol. 2003. PMID: 12615672 Review.
-
Clinically relevant pleiotropic effects of statins: drug properties or effects of profound cholesterol reduction?Nutr Metab Cardiovasc Dis. 2001 Oct;11(5):328-43. Nutr Metab Cardiovasc Dis. 2001. PMID: 11887430 Review.
-
[Statins: possibly more than just lowering of the lipid level].Ned Tijdschr Geneeskd. 2000 Feb 12;144(7):316-21. Ned Tijdschr Geneeskd. 2000. PMID: 10707742 Review. Dutch.
Cited by
-
Pharmacogenomics-based systematic review of coronary artery disease based on personalized medicine procedure.Heliyon. 2024 Mar 29;10(7):e28983. doi: 10.1016/j.heliyon.2024.e28983. eCollection 2024 Apr 15. Heliyon. 2024. PMID: 38601677 Free PMC article.
-
Is LDL cholesterol associated with long-term mortality among primary prevention adults? A retrospective cohort study from a large healthcare system.BMJ Open. 2024 Mar 28;14(3):e077949. doi: 10.1136/bmjopen-2023-077949. BMJ Open. 2024. PMID: 38548371 Free PMC article.
-
The preventative effects of statin on lung cancer development in patients with idiopathic pulmonary fibrosis using the National Health Insurance Service Database in Korea.PLoS One. 2024 Mar 13;19(3):e0299484. doi: 10.1371/journal.pone.0299484. eCollection 2024. PLoS One. 2024. PMID: 38478558 Free PMC article.
-
Novel Perspectives in Chronic Kidney Disease-Specific Cardiovascular Disease.Int J Mol Sci. 2024 Feb 24;25(5):2658. doi: 10.3390/ijms25052658. Int J Mol Sci. 2024. PMID: 38473905 Free PMC article. Review.
-
Sinomenine protects against atherosclerosis in apolipoprotein E-knockout mice by inhibiting of inflammatory pathway.Inflammopharmacology. 2024 Apr;32(2):1387-1400. doi: 10.1007/s10787-024-01437-8. Epub 2024 Mar 2. Inflammopharmacology. 2024. PMID: 38430414
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical